Home
>
National Drug Code (NDC)
>
Doxorubicin Hydrochloride
Doxorubicin Hydrochloride - 63323-883-30 - (DOXORUBICIN HYDROCHLORIDE)
Drug Information of Doxorubicin Hydrochloride
| Product NDC: | 63323-883 |
| Proprietary Name: | Doxorubicin Hydrochloride |
| Non Proprietary Name: | DOXORUBICIN HYDROCHLORIDE |
| Active Ingredient(s): | 2 mg/mL & nbsp; DOXORUBICIN HYDROCHLORIDE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Doxorubicin Hydrochloride
| Product NDC: | 63323-883 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA063277 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000414 |
Package Information of Doxorubicin Hydrochloride
| Package NDC: | 63323-883-30 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-883-30) > 25 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Doxorubicin Hydrochloride
| NDC Code | 63323-883-30 |
| Proprietary Name | Doxorubicin Hydrochloride |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-883-30) > 25 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 63323-883 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DOXORUBICIN HYDROCHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20000414 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | DOXORUBICIN HYDROCHLORIDE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
